Rising Immunoprecipitation To Augment The Growth Of The Global Protein A Resin Market

Protein A Resin Market

 

Protein A Resin Market, By Product (Recombinant Protein A , Natural Protein A), By Matrix Type (Agarose-based, Organic Polymer Based, Glass or Silica Based,), By Application (Antibody Purification , Immunoprecipitation (IP)), By End User (Academic Institutes , Biopharmaceutical Manufacturers, Clinical Research Laboratories,), and By Region (North America, Middle East & Africa Latin America, Asia Pacific, Europe,) - Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030

The global protein A resin market is estimated to be valued at US$ 1.2 billion in 2022 and is expected to exhibit a CAGR of 9.8% over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Protein A is 49kDa protein mainly found in the cell wall of the bacterium Staphylococcus aureus. It is coded by the spa genetic and its control is regulated by DNA, cellular osmolarity along with a two-compound method known as ArIS-ArIR. It gives a structure and assistance for cells, they permit the body to move. They bind and carry atoms along with smaller molecules in the cells and entire body. They are made up by linking very large number of amino acids.

Competitive Landscape:

Key players involved in the global protein A resin market are EMD Millipore, Tosoh Bioscience, Expedeon Ltd, GE Healthcare, Novasep, Purolite Life Sciences, Thermo Fisher Scientific, Repligen and GenScript Biotech Corporation.

Market Key Drivers:

Rising immunoprecipitation is anticipated to augment the growth of the global protein A resin market. Immunoprecipitation is a method of isolating the targeted protein that utilizes the monoclonal antibody. For instance, as per MethodsX 2019, to determine S-glutathionylation in target proteins, immunoprecipitation method was utilized which had protein A resins.

Furthermore, increasing chronic diseases is anticipated to drive in growth of the global protein A resin market. For instance, as per the ACS, in 2019, there would be around 1,762,450 new cancer cases treated and 606,880 cancer mortalities in the U.S.

Covid-19 Impact Analysis:

The outbreak of Covid-19 had led to a positive impact on the global protein A resin market owing to rising R&D activities of pharmacies. It led all the main pharmacies and biopharma companies to develop a vaccine which gives immunity against corona virus, which caused huge production for approved monoclonal antibodies. 

Key Takeaways:

The global protein A resin market is projected to exhibit a CAGR of 9.8 % during the forecast period due to rising need for therapeutics for antibodies and rising R&D activities. For instance, as per the European Medicine Agency, nearly 66 novel medicines and 30 new active materials got approval in Europe as of 2019.

Among regions North America, Asia Pacific and Europe are anticipated to witness robust growth in the global protein A resin due to increasing demand of pharmacies and biopharma. For instance, Centre of Drug Evaluation and Research (CDER) launched nearly 48 new drugs as new molecular entities or biologics as of 2019.